HRP20020735A2 - Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient - Google Patents

Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient

Info

Publication number
HRP20020735A2
HRP20020735A2 HRP20020735A HRP20020735A2 HR P20020735 A2 HRP20020735 A2 HR P20020735A2 HR P20020735 A HRP20020735 A HR P20020735A HR P20020735 A2 HRP20020735 A2 HR P20020735A2
Authority
HR
Croatia
Prior art keywords
hydroxybutylidene
amino
active ingredient
direct compression
bisphosphonic acid
Prior art date
Application number
Other languages
English (en)
Inventor
Dagmar Jaueprovs
Original Assignee
Leciva
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5471285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20020735(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leciva filed Critical Leciva
Publication of HRP20020735A2 publication Critical patent/HRP20020735A2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP20020735 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient HRP20020735A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20002567A CZ289261B6 (cs) 2000-07-11 2000-07-11 Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
PCT/CZ2001/000037 WO2002003963A1 (en) 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1, 1-bisphosphonic acid as active ingredient

Publications (1)

Publication Number Publication Date
HRP20020735A2 true HRP20020735A2 (en) 2004-12-31

Family

ID=5471285

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20020735 HRP20020735A2 (en) 2000-07-11 2001-06-29 Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient

Country Status (17)

Country Link
US (1) US7198802B2 (cs)
EP (1) EP1299088B1 (cs)
AT (1) ATE331502T1 (cs)
AU (1) AU2001270454A1 (cs)
BG (1) BG107520A (cs)
CA (1) CA2415630A1 (cs)
CZ (1) CZ289261B6 (cs)
DE (1) DE60121166D1 (cs)
EE (1) EE200300017A (cs)
HR (1) HRP20020735A2 (cs)
HU (1) HUP0301072A3 (cs)
PL (1) PL360872A1 (cs)
RU (1) RU2279273C2 (cs)
SK (1) SK283249B6 (cs)
UA (1) UA73784C2 (cs)
WO (1) WO2002003963A1 (cs)
YU (1) YU77702A (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6827718B2 (en) 2001-08-14 2004-12-07 Scimed Life Systems, Inc. Method of and apparatus for positioning and maintaining the position of endoscopic instruments
CA2481091A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
GR1004331B (el) * 2002-10-07 2003-09-05 Verisfield (Uk) Ltd Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
EP1781258A1 (en) * 2004-08-20 2007-05-09 Mepha AG Formulations of bisphosphonates
WO2006046100A1 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Pharmaceutical composition of alendronic acid
WO2006054165A1 (en) * 2004-11-19 2006-05-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of alendronic acid and processes for their preparation
ES2507552T3 (es) * 2005-10-27 2014-10-15 Nexilis Ag Implante que contiene amino-bisfosfonatos y procedimiento para su producción
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
NZ591328A (en) * 2008-08-22 2012-11-30 Wockhardt Research Center Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof
EA201190243A1 (ru) * 2009-05-19 2013-01-30 Гриндекс, Э Джоинт Сток Кампани Стабильная фармацевтическая композиция флударабина фосфата
JP5714600B2 (ja) 2009-12-18 2015-05-07 フリースランドカンピナ・ネーデルランド・ホールディング・ビー．ブイ．ＦｒｉｅｓｌａｎｄＣａｍｐｉｎａ Ｎｅｄｅｒｌａｎｄ Ｈｏｌｄｉｎｇ Ｂ．Ｖ． 共加工された錠用賦形剤混合物、その調製及び使用
EP4392024A1 (en) 2021-08-25 2024-07-03 Basf Se Direct tableting auxiliary composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358941A (en) 1992-12-02 1994-10-25 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids with lactose
WO1994026310A1 (de) * 1993-05-15 1994-11-24 Boehringer Mannheim Gmbh Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
JP2002512614A (ja) * 1997-03-26 2002-04-23 セプラコア インコーポレーテッド 化学的かつ熱的に安定なノルアステミゾール製剤
AP2002002641A0 (en) * 2000-04-07 2002-12-31 Pfizer Prod Inc Estrogen agonist metabolites.

Also Published As

Publication number Publication date
EP1299088B1 (en) 2006-06-28
CA2415630A1 (en) 2002-01-17
UA73784C2 (en) 2005-09-15
CZ20002567A3 (cs) 2001-12-12
HUP0301072A2 (hu) 2003-08-28
YU77702A (sh) 2006-05-25
SK5112001A3 (en) 2002-02-05
RU2279273C2 (ru) 2006-07-10
EE200300017A (et) 2004-10-15
BG107520A (bg) 2003-06-30
PL360872A1 (en) 2004-09-20
CZ289261B6 (cs) 2001-12-12
SK283249B6 (sk) 2003-04-01
AU2001270454A1 (en) 2002-01-21
DE60121166D1 (de) 2006-08-10
WO2002003963A1 (en) 2002-01-17
ATE331502T1 (de) 2006-07-15
US20030161878A1 (en) 2003-08-28
HUP0301072A3 (en) 2005-07-28
EP1299088A1 (en) 2003-04-09
US7198802B2 (en) 2007-04-03

Similar Documents

Publication Publication Date Title
NZ507271A (en) Fast disintegrating tablets
HRP20020735A2 (en) Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredient
MY148680A (en) Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
MY151098A (en) Rapidly disintegrable solid preparation
WO2004012700A3 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
AU2509895A (en) Fluoxetine pharmaceutical formulations
PE20001036A1 (es) Tabletas bioadhesivas para hidratacion progresiva y metodos para su elaboracion y uso
CA2422359A1 (en) Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds
NZ524138A (en) Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
CA2382098A1 (en) Sustained-release, oral pharmaceutical forms of administration
EA200000584A2 (ru) Твердые фармацевтические композиции с контролируемым высвобождением, получаемые тепловым формованием
WO2003037860A3 (en) Purine analogs having hsp90-inhibiting activity
CA2339765A1 (en) Compounds and compositions for delivering active agents
WO2002009719A1 (en) Antitumor agents
BG106927A (en) Matrix tablet for prolonged release of trimetazidine after oral administration
WO2000021910A3 (en) 1,2-disubstituted cyclopropanes
AU2002218746A1 (en) Composition comprising folic acid and zinc for improving male fertility
AU4249700A (en) Hydroxamic acid derivative
CA2326339A1 (en) Use of dexmedetomidine for icu sedation
RU2003102448A (ru) Таблетка, получаемая непосредственным прессованием, содержащая 4-амино-1-гидроксибутилиден-1,1-бисфосфоновую кислоту в качестве активного ингредиента
WO2000054780A3 (en) Corticosteroid formulation
WO2002011737A3 (en) Anti-inflammatory medicament
CA2311024A1 (en) Pharmaceutical composition for oral administration of chelating agents
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
IT1273790B (it) Derivati eterociclici diazotati aventi attivita' aii antagonista

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ZENTIVA, A.S., CZ

ODBC Application rejected